Today, I added 3 more stocks to the Own Every Stock Portfolio.  The latest additions to the portfolio include, Vector Group, Ltd. (VGR), CBS Corporation (CBS), and Express Scripts, Inc. (ESRX).  The first two companies are paying very nice dividends while Express Scripts is a fast growing company providing management to the health care industry.  Thus far, I have been hesitant to buy stocks that are not paying a dividend.  Part of this, is due to the fact, that while the market has been slumping and declining, dividend yields will help offset the losses or lack of growth in the general market.  However, I do realize that non-dividend paying companies often grow faster than their dividend paying counterparts, so I have been trying to blend in a few growth companies that are currently not paying a dividend.  In fact, some of my largest holdings are non-dividend paying stocks like Google, Inc. (GOOG) and Apple, Inc. (AAPL).

Vector Group, Ltd. is in the tobacco industry, which is definitely a declining market within the United States.  However, many of the companies within the tobacco industry continue to pay a nice dividend, so I have a few stocks from the industry in the Own Every Stock Portfolio.  I might not agree with a lot of the things big tobacco companies have done over the years, but at least I have a very small say, even if it is insignificant, in what the companies do moving forward.  A quick look at the numbers, show VGR trading at a P/E of around 20 and a dividend yield of around 8.5%.  I am not sure if they can continue to keep paying that high of a dividend into the future, but I will take advantage of it in the meantime.

CBS Corporation is a company almost everyone is familiar with.  The company isn't likely to see any major growth any time soon, but it should continue to plug away and pay a nice dividend.  I also think that the stock may be trading at a slight discount relative to its earnings right now.  CBS is currently trading with a P/E of under 10.  However, with that being said, the company's earnings are expected to move sideways for the next year.  Analysts project the same earnings for next year as this year.  The stock is currently paying a 6% dividend.

My final purchase of the day, Express Scripts, is a company that provides management, compliance support, and supplemental medical services to other pharmaceutical and health care companies.  Express Scripts has been growing at over 30% annualized over the last five years and is expected to grow at nearly 20% for the next five years.  The company may be a little expensive at a trailing P/E near 30, but the forward P/E is a little over 20 based on estimates.  Also, keep in mind, Express Scripts has beat estimates in each of the last 4 quarters.  As always, my opinions on these stocks is worth exactly what you paid for it.